Perrigo names new leader of company's Branded Consumer Healthcare division
DUBLIN - Perrigo on Thursday announced that Sharon Kochan, Perrigo EVP and general manager, international, will have expanded responsibilities that will now include providing leadership and strategic direction to the company's Branded Consumer Healthcare segment following the resignation of Marc Coucke, who previously served as EVP and general manager of the BCH segment.
"Sharon's background and ability to drive individuals and organizations to peak performance made my decision to appoint him to lead the BCH team a clear one," stated John Hendrickson, Perrigo CEO. "Perrigo is well-positioned for a great future, and the BCH team and business are important parts of that future. Perrigo is committed to the long-term prospects for the segment, and I am confident that we have the right team in place to lead and support this growing business during this transition," he said. "Aligned with the actions that we are taking to drive improved performance in the BCH segment, we have accepted the resignation of Marc Coucke. The board and management team wish Marc well in his future endeavors."
Kochan was named Perrigo's EVP and general manager, international in August 2012. He served as EVP and general manager of Rx pharmaceuticals from March 2007 to August 2012 and as SVP business development and strategy from March 2005 to March 2007.
Prior to joining Perrigo, Kochan was VP business development of Agis Industries from July 2001 until the acquisition of Agis by Perrigo in March 2005.
Kochan holds a B.Sc. degree in Industrial Engineering, cum laude, from Tel-Aviv University, and a M.Sc. degree in Management Science - Operations Research from Columbia University in the City of New York.
"Given BCH's expansive distribution platform, strong portfolio of OTC brands and the entrepreneurial spirit of its employees, I am confident that the business is well-positioned for success and I am very pleased to be a part of that promising future," Kochan said.